Cancer

acute myeloid leukemia

Regulation

downregulation

Reporting

The differentially expressed microRNAs miRNAs miR were selected after hybridizing with miRNA microarray real time polymerase chain reaction real-time PCR was subsequently applied to confirm the expression of the selected miRs and PCR products were further cloned and sequenced to check their specificity. Real time PCR verified that the expression level of miR-10a and miR-220c in the CD34+ cells from the bone marrow of AML patients was 19.6% and 19.0% of that of CD34+ cells from mobilized peripheral blood of the normal control subjects. A variety of differentially expressed-miRNAs are existed between AML and normal control subjects CD34+ cells the expression of miR-10a and miR-220c was significantly down-regulated in the CD34+ cells from the bone marrow of AML patients

Pubmed

22967414

Method

qPCR; Microarray

Cancer

acute myeloid leukemia

Regulation

upregulation

Reporting

Serum level of miR 10 5p as a prognostic biomarker for acute myeloid leukemia. The aim of the present study was to investigate the serum expression status and explore the prognostic significance of miR-10a-5p in acute myeloid leukemia AML. The serum expression level of miR-10a-5p in de novo AML was significantly higher compared with that in controls. The area under the receiver operator characteristic ROC curve was of 0.831 in the diagnostic value of miR-10a-5p. In the complete remission CR group the serum expression level of miR-10a-5p was similar to that of healthy subjects and demonstrated a significant downtrend when compared to that on the day of diagnosis. Nevertheless miR-10a-5p expression was found to significantly increase in cases of relapsed AML when compared individually to the CR population. On analysis of the association of miR-10a-5p expression with the clinical characteristics at diagnosis in AML patients lower CR rates occurred more frequently in the high-expression group. In addition high miR-10a-5p expression was associated with poorer overall survival OS. These data suggest that miR-10a-5p may serve as a biomarker useful to improving the management of AML patients

Pubmed

26134365

Method

Cancer

cervical and endocervical cancer

Regulation

upregulation

Reporting

Vote-counting analysis showed that up-regulation was most consistently reported for miR-20a and miR-21 four studies followed by miR-10a miR-15b miR-20b miR-141 miR-200a and miR-224 three studies

Pubmed

25920605

Method

Cancer

cervical and endocervical cancer

Regulation

upregulation

Reporting

Upregulation of miR 20a and miR 10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer. In the current study the expressions of miR-20a and miR-10a were evaluated in the cervical cancer tissues and in the corresponding noncancer tissues using qRT-PCR assay. Survival and Cox proportional hazards analyses were performed to find the association of miR-20a and miR-10a levels with prognosis in the patients. We found that miR-10a was overexpressed in cervical cancer tissues than those corresponding adjacent cervical tissues P < 0.05. Our findings showed that elevated expression of miR-10 was remarkably correlated with advanced FIGO stage P < 0.001 advanced histological grade 0.031 and increased size of the tumors P = 0.024. Kaplan-Meier analysis and log-rank test revealed that cervical cancer patients with high expression of miR-10 have shorter overall survival than patients with low expression log-rank test P < 0.001. Our findings showed that upregulation of miR-20a and miR-10a were correlated with aggressive progression and poor prognosis of cervical cancer

Pubmed

26427662

Method

qPCR

Cancer

gastric cancer

Regulation

deregulation

Reporting

miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR 10a plays a role in metastasis from primary gastric cancer to lymph nodes. A miRNA array was used to compare the expression of miRNAs in primary gastric cancer and paired lymph node metastases. Moreover the target genes for miR-10a were predicted using bioinformatic methods. Based on the results four differentially expressed miRNAs were detected by the miRNA array. Compared with primary gastric cancer lymph node metastases displayed downregulated expression of miR-24-1* miR-510 and miR-1284 while the expression of miR-10a was upregulated. Consequently analysis found that the expression of miR-10a was associated with lymph node metastasis P=0.047 but was independent of the state of lymphatic invasion P=0.169 in the cohort of primary gastric carcinoma. Bioinformatic analysis demonstrated that the target genes of miR-10a are involved in multiple related pathways of tumorigenesis and metastasis. In conclusion our study suggests that miR-10a is involved in the development of gastric cancer and lymph node metastasis particularly in the latter process

Pubmed

22969895

Method

Microarray

Cancer

head and neck cancer

Regulation

deregulation

Reporting

A global miRNA profiling was done on 51 formalin-fixed archival HNSCC samples using quantitative reverse transcription-PCR approach correlated with patients' clinical parameters. Cell viability and proliferation were investigated using MTS and clonogenic assays respectively; cell cycle analyses were assessed using flow cytometry. Upregulation of miR-423 miR-106b miR-20a and miR-16 as well as downregulation of miR-10a were newly observed

Pubmed

20145181

Method

Reverse transcription PCR

Cancer

liver cancer

Regulation

downregulation

Reporting

Because understanding the pathogenesis of viral-associated hepatocellular carcinomas is important in developing effective means of classification prognosis and therapy we examined the microRNA expression profiles in a large set of 52 human primary liver tumors consisting of premalignant dysplastic liver nodules and hepatocellular carcinomas by quantitative real-time polymerase chain reaction. Initially the accessibility of microRNAs from formalin-fixed paraffin-embedded archival liver tissue by real-time polymerase chain reaction assays was shown. Subsequently target parenchyma from routinely processed tissue was macrodissected RNA was extracted and reverse transcription followed by quantitative real-time polymerase chain reaction was performed. Subsequently five microRNAs miR-122 miR-100 miR-10a miR-198 and miR-145 were selected on the basis of the initial results and further examined in an extended tumor sample set of 43 hepatocellular carcinomas and 9 dysplastic nodules. miR-122 miR-100 and miR-10a were overexpressed whereas miR-198 and miR-145 were up to 5-fold down-regulated in hepatic tumors compared to normal liver parenchyma

Pubmed

18307259

Method

qPCR

Cancer

liver cancer

Regulation

downregulation

Reporting

Expression levels of three identified miRNAs miR-10a miR-10b and miR-196b were measured in a subset of 37 HCC tumor and non-tumor tissues. Significant downregulation of miR-10a was observed in tumor compared with non-tumor tissues 0.50 vs 1.73 p = 0.031. These data suggest that aberrant DNA methylation may lead to dysregulation of miR-10a in HCC tumor tissues

Pubmed

22976466

Method

Cancer

lung squamous cell cancer

Regulation

deregulation

Reporting

We further validated our results by RT-qPCR for differentially expressed miRNAs in an independent group of 40 matched fresh frozen tissues 37 plasma samples from NSCLC patients and 28 healthy donors. We found that eight miRNAs miR-21 miR-30d miR-451 miR-10a miR-30e-5p and miR-126* miR-126 miR-145 were differentially expressed by three different statistical analysis approaches. Two of them miR-10a and miR-30e-5p are reported here for the first time. Bead-array results were further verified in an independent group of 40 matched fresh frozen tissues by RT-qPCR. According to RT-qPCR miR-21 was significantly up-regulated P = 0.010 miR-126* P = 0.002 miR-30d P = 0.012 miR-30e-5p P < 0.001 and miR-451 P < 0.001 were down-regulated while miR-10a was not differentiated P = 0.732 in NSCLC tissues. However in NSCLC plasma samples only three of these miRNAs miR-21 miR-10a and miR-30e-5p displayed differential expression when compared to plasma of healthy donors. Moreover we report for the first time that low expression of miR-10a in NSCLC plasma samples was associated with worse DFI P = 0.050 and high expression of miR-30e-5p was found to be associated with shorter OS P = 0.048. In conclusion circulating miR-21 miR-10a and miR-30e-5p in plasma should be further evaluated as potential non-invasive biomarkers in NSCLC

Pubmed

23756108

Method

qPCR

Cancer

lung squamous cell cancer

Regulation

deregulation

Reporting

Other miRNAs including miR-5100 and miR-650 were upregulated while miR-10a and -26b were downregulated in FF NSCLC tissues

Pubmed

26870288

Method

Cancer

lymphoma

Regulation

downregulation

Reporting

The expression levels of miR-10a and miR-342-3p were lower in ENKTCL tissues than in normal NK cells but no significant differences were observed in the expression levels of miR-22 miR-340 and miR-590-5p in ENKTCL tissues compared with normal NK cells. The low expression levels of miR-10a detected in the tissues of patients with ENKTCL were inversely correlated with the age of the patients whereas the low expression levels of miR-342-3p measured in these samples were not correlated with any demographic or clinical features of the patients

Pubmed

26870215

Method

Cancer

pancreatic cancer

Regulation

upregulation

Reporting

Retinoic acid receptor antagonists inhibit miR 10a expression and block metastatic behavior of pancreatic cancer. Northern blot analysis revealed increased expression levels of miR-10a in metastatic pancreatic adenocarcinoma. The role of miR-10a was analyzed by Morpholino and short interfering RNA transfection of pancreatic carcinoma cell lines and resected specimens of human pancreatic carcinoma. We further show that miR-10a is a retinoid acid target and that retinoic acid receptor antagonists effectively repress miR-10a expression and completely block metastasis. Inhibition of miR-10a expression with retinoic acid receptor antagonists or function with specific inhibitors is a promising starting point for antimetastatic therapies

Pubmed

19747919

Method

Northern blot

Cancer

prostate cancer

Regulation

deregulation

Reporting

RESULTS A total of 162 miRNAs were differentially expressed between normal and prostate cancer samples including 128 up-regulated and 38 down-regulated ones; hsa-mir-153-2 hsa-mir-92a-1 and hsa-mir-182 up-regulated; and hsa-mir-29a hsa-mir-10a and hsa-mir-221 down-regulated were identified as good biomarkers

Pubmed

26628405

Method

Cancer

thyroid cancer

Regulation

downregulation

Reporting

Interestingly miR-152-3p miR-185-5p and miR-574-3p were significantly downregulated in NIFTPs compared with follicular adenomas whereas miR-10a-5p and miR-320e can discriminate between NIFTPs and infiltrative forms of follicular variant of papillary thyroid carcinomas

Pubmed

27586203

Method